New Insights into the Interactions between Dendrimers and Surfactants: 2. Design of New Drug Formulations Based on Dendrimer−Surfactant Aggregates

Abstract

The interactions between dendrimers and surfactants led to the formation of aggregates dispersed in aqueous solutions. The potential of the resulting dendrimer-surfactant aggregates as new drug formulations was evaluated. The size, morphology, and stability of the aggregates and the localization of drugs in them were determined by dynamic laser light scattering, atomic force microscopy, agarose gel electrophoresis, and nuclear magnetic resonance studies. The drug-loaded aggregates have a spherical shape and an average size of 40 nm. The drug-loading efficiency of dendrimers is significantly influenced in the presence of surfactants. The release rate of the drugs from the dendrimer-surfactant aggregates can be modulated by varying the amount of surfactant in the aggregates. The dendrimer-surfactant aggregates are promising carriers for hydrophobic drugs in transdermal administration routes.

Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues

“…Dendrimers can be used as dendritic boxes and unimolecular micelles (dendrimer-drug networks) for the incorporation of hydrophobic/hydrophilic molecules by host guest interactions inside their empty cavities (nanoscale containers) present around core. [7879] Jansen et al . were the first to entrap the rose bengal dye molecules in PPI dendrimers by using tert-butyloxycarbonyl (t-Boc) groups and led to the production of stable dendritic box that possess the bulky amino groups on the dendrimer surface.…”

Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs

“…No significant modifications of the zeta potential (∼11–13 mV) or size (10–20 nm) were observed by the incorporation of haloperidol, allowing nose to brain transport as well colloid instabilities. As the size of G5 PAMAM dendrimers is ∼5.4 nm, the formation of soluble aggregates can be envisaged due to the presence of Tween 20 as a surfactant [ 77 ].…”

Potential Application of Dendrimers in Drug Delivery: A Concise Review and Update

“…Dendrimers can be used as dendritic boxes and unimolecular micelles (dendrimer-drug networks) for the incorporation of hydrophobic/hydrophilic molecules by host guest interactions inside their empty cavities (nanoscale containers) present around core. [26][27] Jansen et al were the first to entrap the rose bengal dye molecules in PPI dendrimers by using tert-butyloxycarbonyl (t-Boc) groups and led to the production of stable dendritic box that possess the bulky amino groups on the dendrimer surface. 28 The dendritic unimolecular micelles contain the hydrophobic cores surrounded by hydrophilic shells and they offer an advantage over conventional polymeric micelles such that the micellar structure is maintained at all the concentrations because the hydrophobic segments are covalently connected.…”